FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

FDA Approves Cobenfy for Adults With Schizophrenia

drugs.com - 14/Nov 23:11

THURSDAY, Nov. 14, 2024 -- The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic...

FDA Approves Emrosi for Rosacea in Adults

drugs.com - 12/Nov 21:33

TUESDAY, Nov. 12, 2024 -- The U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride) for the treatment of inflammatory...

FDA Approves Emrosi for Rosacea in Adults

drugs.com - 12/Nov 21:33

TUESDAY, Nov. 12, 2024 -- The U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride) for the treatment of inflammatory...

Nipocalimab is the First and Only Investigational Therapy Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults Living with Moderate-to-Severe Sjögren’s Disease

drugs.com - 11/Nov 02:11

Spring House, PA (November 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has...

RFK Jr. vs. Big Pharma Goliath: What Can Be Done to Rein in Drug Makers, Big Food and the FDA

sputniknews.com - 15/Nov 17:58

Donald Trump has tapped Robert F. Kennedy Jr. for HHS chief - the top advisor to the president on health-related matters, and chief administrator...

FDA Approves Kebilidi (eladocagene exuparvovec-tneq) Gene Therapy for the Treatment of AADC Deficiency

drugs.com - 13/Nov 02:11

WARREN, N.J., Nov. 13, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA)...

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

drugs.com - 04/Nov 23:11

CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...

FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

drugs.com - 08/Nov 21:11

LONDON, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early-commercial stage biopharmaceutical company developing...

Abeona Therapeutics Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa

drugs.com - 12/Nov 20:11

CLEVELAND, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the U.S. Food and Drug Administration (FDA)...

FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine

drugs.com - 07/Nov 16:11

THURSDAY, Nov. 7, 2024 -- More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal...

Rubriques :

FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

Articles similaires

FDA Approves Cobenfy for Adults With Schizophrenia

FDA Approves Emrosi for Rosacea in Adults

FDA Approves Emrosi for Rosacea in Adults

Nipocalimab is the First and Only Investigational Therapy Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults Living with Moderate-to-Severe Sjögren’s Disease

RFK Jr. vs. Big Pharma Goliath: What Can Be Done to Rein in Drug Makers, Big Food and the FDA

FDA Approves Kebilidi (eladocagene exuparvovec-tneq) Gene Therapy for the Treatment of AADC Deficiency

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Abeona Therapeutics Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa

FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine

Les derniers communiqués